However, Kohli et al. found that TTC3 may act like APOE in all members of a family with late-onset AD (LOAD), and TTC3 variants may contribute to LOAD risk, but may not initiate AD pathogenesis like APP (Kohli et al. 2016). Here, APOE is linked to Alzheimer disease.